Emulsion Polymerization of Styrene to Polystyrene Nanoparticles with Self-Emulsifying Nanodroplets as Nucleus.

The mechanism of the emulsion polymerization of styrene to polystyrene nanoparticles (PSNPs) remains a subject of debate. Herein, a series of reaction parameters with different surfactant concentrations, monomer contents, temperatures, and equilibration times were investigated to understand the formation mechanism of PSNPs, which demonstrate a correlation between the properties of PSNPs and the mesostructure of the premix. Cooling the model systems with self-emulsifying nanodroplets (SENDs) in the early reaction stages resulted in the hollow polystyrene spheres (H-PSSs), ruptured PSNPs, and dandelion-like PSNPs, further indicating that the oil nanodroplets are the key sites for the formation of PSNPs.

Fabrication of tetraethyl orthosilicate/ethanol-water surfactant-free microemulsions and their applications in self-templating synthesis of monodispersed silica colloidal spheres.

Surfactant-free microemulsions (SFMEs) composed of tetraethyl orthosilicate (TEOS), ethanol, and water have been successfully fabricated by visual titration and electrical conductivity methods. Three types of SFMEs, water in TEOS (W/O), bicontinuous (BC) and TEOS in water (O/W), were identified by dynamic light scattering and transmission electron microscopy with negative-staining methods. We demonstrated that there are significant differences in the properties of silica products synthesized with different types of SFMEs, and monodispersed silica colloidal spheres (MSCSs) can only be synthesized in the O/W type SFMEs.

A penta-component mpox mRNA vaccine induces protective immunity in nonhuman primates.

The recent worldwide outbreaks of mpox prioritize the development of a safe and effective mRNA vaccine. The contemporary mpox virus (MPXV) exhibits changing virological and epidemiological features, notably affecting populations already vulnerable to human immunodeficiency virus (HIV). Herein, we profile the immunogenicity of AR-MPXV5, a penta-component mRNA vaccine targeting five specific proteins (M1R, E8L, A29L, A35R, and B6R) from the representative contemporary MPXV clade II strain, in both naive and simian immunodeficiency virus (SIV)-infected nonhuman primates.

TLR7 Agonist GS-9620 Combined with Nicotinamide Generate Viral Reactivation in Seronegative SHIV-Infected Rhesus Monkeys.

Antiretroviral therapy is capable of inhibiting HIV replication, but it fails to completely achieve a cure due to HIV persistence. The commonly used HIV cure approach is the "shock and kill" strategy, which employs latency-reversing agents to trigger viral reactivation and boost cellular immunity. Finding the appropriate drug combination for the "shock and kill" strategy would greatly facilitate clinical trials.

Protocol for evaluating CD8 T cell-mediated immunity in latently SHIV-infected rhesus macaques with HIV fusion-inhibitory lipopeptide monotherapy.

Strong cellular immunity contributes to the control of HIV infection. Here, we describe a step-by-step protocol to assess the simian immunodeficiency virus (SIV)-specific CD8 T cell responses by quantifying the degranulation, cytokine and chemokine production from SHIV-infected rhesus macaques with an HIV fusion-inhibitory lipopeptide (LP-98) monotherapy. We also present the steps for adoptive transfer of an anti-CD8 antibody into a stable virologic control (SVC) group of LP-98-treated monkeys, confirming a direct role of CD8 T cells in SVC macaques.

Efficient treatment and pre-exposure prophylaxis in rhesus macaques by an HIV fusion-inhibitory lipopeptide.

Two HIV fusion-inhibitory lipopeptides (LP-97 and LP-98) were designed with highly potent, long-acting antiviral activity. Monotherapy using a low dose of LP-98 sharply reduced viral loads and maintained long-term viral suppression in 21 SHIV-infected rhesus macaques. We found that five treated monkeys achieved potential posttreatment control (PTC) efficacy and had lower viral DNA in deep lymph nodes, whereas monkeys with a stable viral rebound had higher viral DNA in superficial lymph nodes.

Stage-Dependent Within-Individual Comparison Reveals SIV-Specific Activation/Exhaustion Shift in Rhesus Macaques.

It is challenging to trace the complicated individual-based variations of HIV-specific immunocompetence shift during the successful antiretroviral therapy (ART) era. Using eight rhesus monkeys simulating a longitudinal stage-dependent cohort (baseline-SIV acute infection-SIV suppression by ART-ART withdrawal), baseline immunocompetence monitoring for 28 days (SIV-negative stage, SN) was compared with host immunocompetence undergoing 90-day ART treatment (SIV-suppressed stage, SS) to reveal the SIV-specific immunity shift aroused by undetectable individual viral replication. During acute SIV infection for 98 days (SIV-emerged stage, SE), immune activation was compared with re-immune activation post ART for 49-day follow-up (SIV-rebounded stage, SR) to reveal the SIV-specific immune activation variation aroused by detectable individual viral replication.

Molecular cloning and differential expression patterns of the regulatory subunit B' gene of PP2A in goldfish, Carassius auratus.

It is well established that the protein serine/threonine phosphatase 2A (PP2A) plays very important roles in many different cellular processes, including cell proliferation and differentiation, gene expression, neurotransmission, apoptosis, and aging. PP2A consists of three heterogenic subunits: the scaffold subunit A, the catalytic subunit C, and the regulatory subunit B. While both the scaffold and the catalytic subunits contain only two forms, at least four families of the regulatory subunits, B, B', B'', and B''' have been identified.